½ÃÀ庸°í¼­
»óǰÄÚµå
1599201

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå : ¿øÀÚÀç, ÄÚÆÃ À¯Çü, Á¦Ç° À¯Çü, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Vascular Guidewires Market by Raw Material (Nitinol, Stainless Steel), Coating Type (Hydrophilic Polymer, Hydrophobic Polymer), Product, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀº 2023³â 10¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 11¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 8.13% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 18¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀǴ ƯÈ÷ ½ÉÀåÇÐ, ½Å°æÇÐ ¹× ¸»ÃÊÇ÷°ü ÁßÀç¼ú°ú °°Àº ÃÖ¼Òħ½À ¼ö¼ú¿¡¼­ Ç÷°ü °¡À̵å¿ÍÀ̾îÀÇ Áß¿äÇÑ ¿ªÇÒÀ» Áß½ÉÀ¸·Î ÀÌ·ç¾îÁý´Ï´Ù. Ç÷°ü °¡À̵å¿ÍÀ̾î´Â ½ºÅÙÆ®, Ä«Å×ÅÍ ¹× ±âŸ ÁßÀç½Ã¼ú ±â±¸¸¦ ÀåÂøÇϰí Ç÷°ü ½Ã½ºÅÛÀ» Ž»öÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ½Ã¼ú Áß Á¤È®¼º°ú Á¦¾î¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC) ¹× Àü¹® Ŭ¸®´Ð¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡, Ä£¼ö¼º ÄÚÆÃ ¹× ÇÏÀ̺긮µå µðÀÚÀÎ °³¹ß µî °¡À̵å¿ÍÀÌ¾î ±â¼úÀÇ ¹ßÀü, ÃÖ¼Òħ½À ¼ö¼ú·ÎÀÇ Àüȯ µî¿¡ ÀÇÇØ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Áß¿äÇÑ ºñÁî´Ï½º ±âȸ´Â ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÀÎ½Ä Áõ°¡°¡ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ½ÅÈï ½ÃÀå¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ´õ ³ªÀº Á¦¾î·Â, À¯¿¬¼º, Ç÷°ü ¿Ü»ó °¨¼Ò¸¦ Á¦°øÇÏ´Â Â÷¼¼´ë °¡À̵å¿ÍÀ̾ °³¹ßÇϱâ À§ÇØ R&D¿¡ ÅõÀÚÇϰí, ½Ã¼ú °èȹ ¹× ½ÇÇàÀ» À§ÇÑ µðÁöÅÐ ¹× AI ±â¹Ý ±â´ÉÀ» °­È­ÇÏ´Â °ÍÀ» °í·ÁÇÒ ¼ö ÀÖ½À´Ï´Ù. ÷´Ü ÀÇ·á±â¼úÀÇ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, º¹ÀâÇÑ ½ÂÀÎ ÀýÂ÷·Î ÀÎÇØ Á¦Ç° Ãâ½Ã°¡ Áö¿¬µÇ´Â µî ½ÃÀå ÇѰ谡 ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±âÁ¸ ºê·£µå¿ÍÀÇ °æÀïÀº ½Å±Ô ÁøÃâ±â¾÷¿¡°Ô µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19 ÆÒµ¥¹ÍÀº »ý»ê°ú °ø±Þ¸ÁÀ» ÀϽÃÀûÀ¸·Î È¥¶õ¿¡ ºü¶ß·Á ½ÃÀå¿¡ ¾Ç¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Çõ½Å°¡µéÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ȯ°æ ±âÁØÀ» ÃæÁ·Çϱâ À§ÇØ ÀÏȸ¿ë °¡À̵å¿ÍÀ̾îÀÇ »ýüÀûÇÕ¼ºÀ» ³ôÀ̰í ȯ°æ ģȭÀûÀÎ Àç·á¸¦ ޱ¸ÇÏ´Â µ¥ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Çù¾÷À» ÅëÇØ Á¦Ç°¿¡ ´ëÇÑ Çǵå¹éÀ» ½ÇÁúÀûÀÎ °³¼±À¸·Î ÀüȯÇÏ´Â °Íµµ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í ºü¸¥ ±â¼ú ¹ßÀü°ú ÁÖ¿ä ±â¾÷ °£ÀÇ Çù·Â °ü°è Áõ°¡·Î Ư¡Áö¾îÁö¸ç, ½ÃÀåÀÇ ÀáÀç·ÂÀ» Ȱ¿ëÇϱâ À§Çؼ­´Â ²÷ÀÓ¾ø´Â ÀûÀÀ°ú Àû±ØÀûÀÎ Àü·« ¼ö¸³ÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 10¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 11¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 18¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 8.13%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°üÁúȯ ¹× ½ÅÀå Áúȯ Áõ°¡·Î ÀÎÇÑ ÁßÀçÀû Ä¡·áÀÇ Çʿ伺
    • ÃÖ¼Òħ½ÀÀû Ç÷°ü ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç° ȸ¼ö ¹ß»ý
    • ÃÖ¼Òħ½À ¼ö¼úÀ» ÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ ¿Ü°ú ÀÇ»ç ºÎÁ·
  • ½ÃÀå ±âȸ
    • °¡À̵å¿ÍÀ̾îÀÇ ±â¼úÀû Áøº¸
    • ÃÖ¼Òħ½À¼ö¼ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¸¥ ½ÅÈï±¹¿¡¼­ÀÇ °¡´É¼º
  • ½ÃÀå °úÁ¦
    • Ç÷°ü °¡À̵å¿ÍÀ̾î¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë

Porter's Five Forces : Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸³´Ï´Ù.

Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå : ¿øÀÚÀ纰

  • ´ÏƼ³î
  • ½ºÅ×Àθ®½º°­

Á¦7Àå Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå : ÄÚÆÃ À¯Çüº°

  • Ä£¼ö¼º Æú¸®¸Ó
  • ¼Ò¼ö¼º Æú¸®¸Ó

Á¦8Àå Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå : Á¦Ç°º°

  • °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾î
  • ½Å°æÇ÷°ü °¡À̵å¿ÍÀ̾î
  • ¸»ÃÊ °¡À̵å¿ÍÀ̾î
  • ºñ´¢±â°ú °¡À̵å¿ÍÀ̾î

Á¦9Àå Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷°ü °¡À̵å¿ÍÀÌ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Asahi Intecc USA Inc.
  • B. Braun Melsungen AG
  • Biotronik SE
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Cordis Corporation
  • Heraeus Holding GmbH
  • Integer Holdings Corporation
  • Koninklijke Philips N.V.
  • Medtronic Plc
  • Scientia Vascular Inc.
  • SCW Medicath Ltd
  • SP Medical A/S
  • Terumo Corporation
  • Vygon SAS
ksm 24.12.03

The Vascular Guidewires Market was valued at USD 1.06 billion in 2023, expected to reach USD 1.14 billion in 2024, and is projected to grow at a CAGR of 8.13%, to USD 1.83 billion by 2030.

The scope and definition of the vascular guidewires market primarily center around their critical role in minimally invasive surgical procedures, particularly in cardiology, neurology, and peripheral vascular interventions. Vascular guidewires are essential for navigating through vascular systems, aiding in the placement of stents, catheters, and other interventional devices. They are pivotal in facilitating precision and control during procedures, leading to their necessity across hospitals, ambulatory surgical centers, and specialty clinics. Market growth is strongly influenced by the increasing prevalence of cardiovascular diseases, advancements in guidewire technology-such as the development of hydrophilic coatings and hybrid designs-and the shift towards minimally invasive surgeries. A key opportunity lies in emerging markets, where healthcare infrastructure improvements and rising awareness are driving demand. Companies might consider investing in R&D to develop next-generation guidewires that offer better control, flexibility, and reduced trauma to vessels, as well as exploring digital and AI-driven enhancements for procedural planning and execution. Market limitations include the high cost of advanced medical technologies, stringent regulatory requirements, and the complex approval processes, which can delay product launches. Additionally, competition from established brands may pose challenges for new entrants. Moreover, the COVID-19 pandemic has temporarily disrupted the production and supply chain, affecting the market negatively. Innovators should focus on enhancing biocompatibility and exploring eco-friendly materials for disposable guidewires to achieve better patient outcomes and meet environmental standards. Collaboration with healthcare providers to streamline product feedback into actionable improvements can also drive innovation. The market is dynamic, characterized by rapid technological advancements and increasing collaborations among key players, emphasizing the need for constant adaptation and proactive strategy formulation to harness market potential.

KEY MARKET STATISTICS
Base Year [2023] USD 1.06 billion
Estimated Year [2024] USD 1.14 billion
Forecast Year [2030] USD 1.83 billion
CAGR (%) 8.13%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Guidewires Market

The Vascular Guidewires Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need of intervention procedures due to increasing instances of cardiovascular and renal diseases
    • Rising demand for minimally invasive vascular surgeries
  • Market Restraints
    • Incidences of product recall
    • Limited availability of skilled surgeons to conduct minimally invasive surgeries
  • Market Opportunities
    • Technological advancements in guidewires
    • Potential in emerging economies owing to increasing awareness about minimally invasive surgeries
  • Market Challenges
    • High cost associated with the vascular guidewire

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Guidewires Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Guidewires Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Guidewires Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Guidewires Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Guidewires Market

A detailed market share analysis in the Vascular Guidewires Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Guidewires Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Guidewires Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Guidewires Market

A strategic analysis of the Vascular Guidewires Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Guidewires Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Intecc USA Inc., B. Braun Melsungen AG, Biotronik SE, Boston Scientific Corporation, Cook Medical Inc., Cordis Corporation, Heraeus Holding GmbH, Integer Holdings Corporation, Koninklijke Philips N.V., Medtronic Plc, Scientia Vascular Inc., SCW Medicath Ltd, SP Medical A/S, Terumo Corporation, and Vygon SAS.

Market Segmentation & Coverage

This research report categorizes the Vascular Guidewires Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Raw Material, market is studied across Nitinol and Stainless Steel.
  • Based on Coating Type, market is studied across Hydrophilic Polymer and Hydrophobic Polymer.
  • Based on Product, market is studied across Coronary Guidewire, Neurovascular Guidewire, Peripheral Guidewire, and Urology Guidewire.
  • Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need of intervention procedures due to increasing instances of cardiovascular and renal diseases
      • 5.1.1.2. Rising demand for minimally invasive vascular surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall
      • 5.1.2.2. Limited availability of skilled surgeons to conduct minimally invasive surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in guidewires
      • 5.1.3.2. Potential in emerging economies owing to increasing awareness about minimally invasive surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. High cost associated with the vascular guidewire
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Guidewires Market, by Raw Material

  • 6.1. Introduction
  • 6.2. Nitinol
  • 6.3. Stainless Steel

7. Vascular Guidewires Market, by Coating Type

  • 7.1. Introduction
  • 7.2. Hydrophilic Polymer
  • 7.3. Hydrophobic Polymer

8. Vascular Guidewires Market, by Product

  • 8.1. Introduction
  • 8.2. Coronary Guidewire
  • 8.3. Neurovascular Guidewire
  • 8.4. Peripheral Guidewire
  • 8.5. Urology Guidewire

9. Vascular Guidewires Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital

10. Americas Vascular Guidewires Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vascular Guidewires Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Guidewires Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Asahi Intecc USA Inc.
  • 3. B. Braun Melsungen AG
  • 4. Biotronik SE
  • 5. Boston Scientific Corporation
  • 6. Cook Medical Inc.
  • 7. Cordis Corporation
  • 8. Heraeus Holding GmbH
  • 9. Integer Holdings Corporation
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic Plc
  • 12. Scientia Vascular Inc.
  • 13. SCW Medicath Ltd
  • 14. SP Medical A/S
  • 15. Terumo Corporation
  • 16. Vygon SAS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦